AU2002354334A1 - Use of totle saponins compounds and a pharmaceutical composition containing totle saponins compounds - Google Patents

Use of totle saponins compounds and a pharmaceutical composition containing totle saponins compounds

Info

Publication number
AU2002354334A1
AU2002354334A1 AU2002354334A AU2002354334A AU2002354334A1 AU 2002354334 A1 AU2002354334 A1 AU 2002354334A1 AU 2002354334 A AU2002354334 A AU 2002354334A AU 2002354334 A AU2002354334 A AU 2002354334A AU 2002354334 A1 AU2002354334 A1 AU 2002354334A1
Authority
AU
Australia
Prior art keywords
totle
saponins compounds
pharmaceutical composition
composition containing
saponins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002354334A
Inventor
Li Li
Xiao Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002354334A1 publication Critical patent/AU2002354334A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002354334A 2001-12-03 2002-12-03 Use of totle saponins compounds and a pharmaceutical composition containing totle saponins compounds Abandoned AU2002354334A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN01142574A CN1422861A (en) 2001-12-03 2001-12-03 Use of saponin
CN01142574.1 2001-12-03
PCT/CN2002/000862 WO2003048182A1 (en) 2001-12-03 2002-12-03 Use of totle saponins compounds and a pharmaceutical composition containing totle saponins compounds

Publications (1)

Publication Number Publication Date
AU2002354334A1 true AU2002354334A1 (en) 2003-06-17

Family

ID=4676832

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002354334A Abandoned AU2002354334A1 (en) 2001-12-03 2002-12-03 Use of totle saponins compounds and a pharmaceutical composition containing totle saponins compounds

Country Status (3)

Country Link
CN (1) CN1422861A (en)
AU (1) AU2002354334A1 (en)
WO (1) WO2003048182A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102274296B (en) * 2010-06-13 2013-05-08 首都医科大学 Application of tenuigenin in preparing medicament for preventing or treating parkinson' disease (PD)
US11857592B2 (en) * 2020-12-14 2024-01-02 Biolite, Inc. Polygala extract for the treatment of attention-deficit hyperactivity disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1083819A (en) * 1993-05-11 1994-03-16 富宁制药厂 Notoginseng total saponin medicines and preparation method thereof
CN1131237C (en) * 1997-09-26 2003-12-17 中国人民解放军军事医学科学院放射医学研究所 Usage of steroi saponin for preventing and curing senile dementia and new steroid saponin

Also Published As

Publication number Publication date
WO2003048182A1 (en) 2003-06-12
CN1422861A (en) 2003-06-11

Similar Documents

Publication Publication Date Title
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2002335536A1 (en) Pyrimidine compound and medicinal composition thereof
HUS1400025I1 (en) Phenethanolamine derivatives and pharmaceutical composition containing them
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2002352420A1 (en) Pyrazine compounds and pharmaceutical compositions containing them
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
AU2002217464A1 (en) Medicinal compositions containing aspirin
AU2002302147A1 (en) Pharmaceutical composition
AU2002257562A1 (en) Deuterated 3-Piperidinopropiophenone and medicaments containing said compounds
AU2002258221A1 (en) Medicinal composition
AU2001290239A1 (en) Medicinal composition
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2002230781A1 (en) Pharmaceutical uses and synthesis of benzobicyclooctanes
AU2002308889A1 (en) Novel heterocyclic compound and medicinal use thereof
AU2002244865A1 (en) Pharmaceutical composition of ibuprofen
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2002354334A1 (en) Use of totle saponins compounds and a pharmaceutical composition containing totle saponins compounds
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2002354460A1 (en) Medicinal composition
AU2001262928A1 (en) Pharmaceutical compositions and their use
AUPR529701A0 (en) Pharmaceutical composition
AU2002215923A1 (en) Use of medicaments

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase